Insufficient scRNA-seq data for expression of ARHGAP11B at single-cell level.
Insufficient scRNA-seq data for expression of ARHGAP11B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 95% | 117.86 | 20 / 21 | 16% | 0.35 | 80 / 504 |
esophagus | 90% | 240.13 | 1294 / 1445 | 21% | 0.31 | 38 / 183 |
uterus | 84% | 81.53 | 142 / 170 | 26% | 0.42 | 118 / 459 |
lung | 98% | 209.71 | 569 / 578 | 10% | 0.18 | 111 / 1155 |
skin | 100% | 585.43 | 1806 / 1809 | 6% | 0.08 | 26 / 472 |
intestine | 96% | 305.66 | 927 / 966 | 9% | 0.15 | 45 / 527 |
thymus | 96% | 110.56 | 625 / 653 | 9% | 0.20 | 53 / 605 |
stomach | 92% | 200.82 | 329 / 359 | 8% | 0.20 | 24 / 286 |
spleen | 100% | 406.27 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 93% | 119.80 | 229 / 245 | 1% | 0.01 | 4 / 502 |
adipose | 94% | 121.91 | 1133 / 1204 | 0% | 0 | 0 / 0 |
breast | 90% | 107.55 | 412 / 459 | 3% | 0.06 | 30 / 1118 |
adrenal gland | 89% | 111.33 | 230 / 258 | 2% | 0.02 | 4 / 230 |
ovary | 84% | 87.09 | 152 / 180 | 3% | 0.05 | 14 / 430 |
peripheral blood | 83% | 627.92 | 774 / 929 | 0% | 0 | 0 / 0 |
pancreas | 77% | 70.27 | 253 / 328 | 5% | 0.10 | 9 / 178 |
muscle | 68% | 88.34 | 544 / 803 | 0% | 0 | 0 / 0 |
brain | 64% | 101.20 | 1680 / 2642 | 2% | 0.04 | 16 / 705 |
blood vessel | 59% | 58.08 | 792 / 1335 | 0% | 0 | 0 / 0 |
kidney | 58% | 65.21 | 52 / 89 | 1% | 0.02 | 8 / 901 |
heart | 56% | 52.06 | 482 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 0.95 | 16 / 29 |
liver | 47% | 39.42 | 106 / 226 | 1% | 0.02 | 6 / 406 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.25 | 8 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0021987 | Biological process | cerebral cortex development |
GO_0006543 | Biological process | glutamine catabolic process |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0035795 | Biological process | negative regulation of mitochondrial membrane permeability |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP11B |
Protein name | Inactive Rho GTPase-activating protein 11B (Rho-type GTPase-activating protein 11B) ARHGAP11B |
Synonyms | FAM7B1 |
Description | FUNCTION: Hominin-specific protein that promotes development and evolutionary expansion of the brain neocortex . Able to promote amplification of basal progenitors in the subventricular zone, producing more neurons during fetal corticogenesis, thereby playing a key role in neocortex expansion . Promotes the proliferation of basal progenitors by inhibiting the mitochondrial permeability transition pore (mPTP): delays the opening of the mPTP via interaction with ADP:ATP translocase, thereby increasing mitochondrial Ca(2+) concentration and inducing glutamine catabolism, which is required for basal progenitor proliferation . Does not possess GTPase activator activity: the absence of GTPase activator activity is required to promote amplification of basal progenitors during neocortex development . . |
Accessions | ENST00000697964.2 Q3KRB8 ENST00000650801.2 A0A2X0SFT2 ENST00000651601.2 ENST00000693711.1 ENST00000621228.1 ENST00000428041.4 |